People: Cempra Inc (CEMP.O)

CEMP.O on Nasdaq

21.61USD
26 Dec 2014
Price Change (% chg)

$0.95 (+4.60%)
Prev Close
$20.66
Open
$20.54
Day's High
$21.68
Day's Low
$20.48
Volume
464,691
Avg. Vol
469,176
52-wk High
$21.90
52-wk Low
$8.10

Search Stocks

Goldstein, Dov 

Brief Biography

Dr. Dov A. Goldstein, M.D., is an Independent Director of Cempra, Inc. He has been a partner at Aisling Capital since 2008. From 2006 to 2008, he was a Principal at Aisling Capital. From 2000 to 2005, Dr. Goldstein was Executive Vice President and Chief Financial Officer of Vicuron Pharmaceuticals, Inc. (acquired by Pfizer Inc.). From 1998 to 2000, Dr. Goldstein was Director of Venture Analysis at HealthCare Ventures, a privately-held investment fund. Dr. Goldstein is a director of several privately held organizations including ADMA Biologics, Inc., Cardiokine, Inc., Durata Therapeutics, Inc., Esperion Therapeutics, Inc., Topaz Pharmaceuticals, Inc. and Scerene Healthcare, Inc. He holds a B.S. in biology from Stanford University, an M.D. from the Yale School of Medicine and an M.B.A. from the Columbia Business School.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks